Investors bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Friday. $77.55 million flowed into the stock on the tick-up and $44.94 million flowed out of the stock on the tick-down, for a money net flow of $32.61 million into the stock. Of all stocks tracked, CVS Health Corporation had the 20th highest net in-flow for the day. CVS Health Corporation traded down ($0.03) for the day and closed at $93.37

Several brokerages have issued reports on CVS. FBR & Co reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Saturday, May 14th. Deutsche Bank AG boosted their price target on shares of CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research report on Wednesday, June 22nd. Argus reissued a “buy” rating and set a $120.00 price target on shares of CVS Health Corporation in a research report on Thursday, August 4th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Finally, Zacks Investment Research raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Six research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $113.02.

The stock’s 50-day moving average price is $95.90 and its 200 day moving average price is $98.51. The firm has a market capitalization of $100.05 billion and a PE ratio of 21.59.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. The firm earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. The business’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.19 earnings per share. On average, analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

Other institutional investors have recently added to or reduced their stakes in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in CVS Health Corporation by 1.0% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 72,347 shares of the pharmacy operator’s stock valued at $7,073,000 after buying an additional 741 shares in the last quarter. Advantus Capital Management Inc raised its position in CVS Health Corporation by 1.8% in the fourth quarter. Advantus Capital Management Inc now owns 106,662 shares of the pharmacy operator’s stock valued at $10,428,000 after buying an additional 1,899 shares in the last quarter. Sawtooth Asset Management Inc. raised its position in CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 5,203 shares in the last quarter. Twin Capital Management Inc. raised its position in CVS Health Corporation by 8.8% in the fourth quarter. Twin Capital Management Inc. now owns 95,854 shares of the pharmacy operator’s stock valued at $9,372,000 after buying an additional 7,760 shares in the last quarter. Finally, Century Capital Management LLC raised its position in CVS Health Corporation by 44.8% in the fourth quarter. Century Capital Management LLC now owns 47,504 shares of the pharmacy operator’s stock valued at $4,644,000 after buying an additional 14,708 shares in the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.